Endobronchial Intubation of Double-lumen Tube: Conventional Method vs Fiberoptic Bronchoscope Guide Method

September 6, 2019 updated by: Jin-Woo Park, Seoul National University Bundang Hospital

The Effect of Endobronchial Intubation of Double-lumen Tube on Post-operative Sore Throat, Hoarseness and Airway Injuries: A Comparison Between Conventional and Fiberoptic Bronchoscope-guided Intubation

Double lumen tube (DLT) needs to be intubated to isolate ventilations of left and right lungs for thoracic surgery. Post-operative sore throat and hoarseness are more frequent with DLT intubation than with single one. Which is may because DLT is relatively thicker, harder, sideway curved and therefore more likely to damage the vocal cord or trachea during intubation, and advanced deeper to the carina and main bronchus level. In the conventional method of intubation, DLT is rotated 90 degrees and advanced blindly to the main bronchus level after DLT is intubated through vocal cord using the direct laryngoscopy. After the blind advancement, the sufficient tube position needs to be gained and confirmed with the fiberoptic bronchoscope. In the bronchoscope guide method, after DLT is intubated through vocal cord using the direct laryngoscopy, the pathway into the targeted main bronchus is secured using the fiberoptic bronchoscope which is passed through a bronchial lumen of DLT. And then DLT can be advanced through the guide of the bronchoscope. In this study, we intend to compare post-operative sore throat, hoarseness and airway injury between the two methods. We hypothesize that the bronchoscope guide method can reduce the post-operative complications and airway injury because surrounding tissues of the airway can be less irritated by DLT intubation in the guide method than in a conventional.

For a constant guide effect, we use fiberoptic bronchoscopes with same outer diameter (4.1 mm) which can pass through a bronchial lumen of 37 and 39 Fr Lt. DLT and cannot pass through 35 Fr or smaller Lt. DLTs.

<Lt. DLT size selection>

  • male: ≥160 cm, 39 French; < 160 cm, 37 French
  • female: ≥160 cm, 37 French; < 160 cm, contraindication

Study Overview

Study Type

Interventional

Enrollment (Actual)

136

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi-do
      • Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA (American Society of Anesthesiologists) class I - III
  • Elective thoracic surgery
  • Left-sided DLT intubation for one-lung ventilation

Exclusion Criteria:

  • Female, height < 160 cm
  • Pre-existing sore throat, hoarseness or airway injury
  • Duration of surgery > 6 h
  • Upper respiratory tract infection
  • Cervical spine diseases
  • Presence of tracheostomy
  • Pharyngeal neoplasm or abscess which can induce mechanical airway obstruction
  • Mallampati score 4
  • Obesity (BMI ≥ 35 kg/m2)
  • Obstructive sleep apnea (OSA)
  • Craniofacial anomaly
  • Cormack grade 3b or 4
  • History or high risk of difficult intubation / difficult mask ventilation
  • Patients whom the direct laryngoscopy cannot be used for, because of weak teeth or small mouth opening
  • Patients who refuse to participate in the study or from whom receive informed consent cannot be received.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bronchoscope guide group
DLT is advanced into the main bronchus through the guide of fiberoptic bronchoscope (Bronchoscope guided advancement).

During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the bronchoscope-guided method. The method is as follows.

  1. Lt. DLT is intubated through vocal cord using the direct laryngoscopy.
  2. Pass the fiberoptic bronschoscope through a bronchial lumen of Lt. DLT.
  3. Secure the pathway into the Lt. main bronchus by advancing the bronchoscope into the Lt. main bronchus.
  4. Lt. DLT can be advanced through the guide of the bronchoscope into Lt. main bronchus.
  5. After the advancement, the position of Lt. DLT can be confirmed using the fiberoptic bronchoscope. If necessary, the depth and direction of Lt. DLT should be modified.
Active Comparator: Conventional group
DLT is advanced blindly to the main bronchus level (Conventional advancement).

During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the conventional method. The method is as follows.

  1. Lt. DLT is intubated through vocal cord using the direct laryngoscopy.
  2. Rotate Lt. DLT 90 degrees to the left side.
  3. Advance Lt. DLT blindly to main bronchus level.
  4. After the advancement, the position of Lt. DLT can be confirmed using the fiberoptic bronchoscope. If necessary, the depth and direction of Lt. DLT should be modified.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative sore throat (24 h)
Time Frame: 24 hour after tracheal extubation
The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most
24 hour after tracheal extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resistance against DLT passage through vocal cord
Time Frame: Intraoperative
none/mild/severe
Intraoperative
Resistance against DLT advancement
Time Frame: Intraoperative
none/mild/severe
Intraoperative
Intubation time
Time Frame: Intraoperative
stop of initial mask ventilation - intubation through vocal cord
Intraoperative
The number of attempts for intubation
Time Frame: Intraoperative
The number of attempts for intubation through vocal cord
Intraoperative
The number of right misplacement of Lt. DLT
Time Frame: Intraoperative
The number of right misplacement of Lt. DLT confirmed using the fiberoptic bronchoscope after the advancement
Intraoperative
Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning
Time Frame: Intraoperative
Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning into Lt. main bronchus
Intraoperative
Heart rate
Time Frame: Intraoperative
Heart rate Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning
Intraoperative
Mean arterial pressure
Time Frame: Intraoperative
Mean arterial pressure Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning
Intraoperative
IV PCA
Time Frame: At 24 hours after the extubation
Fentanyl usage with PCA
At 24 hours after the extubation
Airway injury (Lt. main bronhcus, carina, trachea)
Time Frame: Intraoperative
When spontaneous breathing of the patient starts after the thoracic surgery
Intraoperative
Airway injury (vocal cord)
Time Frame: Intraoperative
When spontaneous breathing of the patient starts after the thoracic surgery
Intraoperative
Post-operative sore throat (1 h)
Time Frame: 24 hours after tracheal extubation
The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most pain) after tracheal extubation
24 hours after tracheal extubation
Post-operative hoarseness (1 h)
Time Frame: 1 hour after tracheal extubation
The incidence of hoarseness after tracheal extubation
1 hour after tracheal extubation
Post-operative hoarseness (24 h)
Time Frame: 24 hour after tracheal extubation
The incidence of hoarseness after tracheal extubation
24 hour after tracheal extubation
Oral dryness
Time Frame: 24 hours after tracheal extubation
The incidence of oral dryness
24 hours after tracheal extubation
Dysphagia
Time Frame: 24 hours after tracheal extubation
The incidence of dysphagia
24 hours after tracheal extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2018

Primary Completion (Actual)

January 30, 2019

Study Completion (Actual)

January 31, 2019

Study Registration Dates

First Submitted

December 1, 2017

First Submitted That Met QC Criteria

December 5, 2017

First Posted (Actual)

December 11, 2017

Study Record Updates

Last Update Posted (Actual)

September 10, 2019

Last Update Submitted That Met QC Criteria

September 6, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Bronchoscope guided advancement

3
Subscribe